Literature DB >> 6667704

Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.

H Hundeshagen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667704     DOI: 10.1007/bf00251617

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


× No keyword cloud information.
  22 in total

1.  Chemotherapy of thyroid cancer with adriamycin. Experience with 30 patients.

Authors:  J A Gottlieb; C S Hill
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

2.  Pulmonary metastases from differentiated thyroid carcinoma demonstrable only by nuclear imaging.

Authors:  F J Bonte; R W McConnell
Journal:  Radiology       Date:  1973-06       Impact factor: 11.105

3.  Pulmonary metastases from differentiated thyroid carcinoma detected only by radionuclide imaging.

Authors:  D Casara; P L Zorat; B Busnardo; M E Girelli
Journal:  Br J Radiol       Date:  1981-04       Impact factor: 3.039

4.  [Therapy of the metastasizing adenocarcinoma of the thyroid gland using 131-I. Experiences with 103 patients from 1963 to 1977 (author's transl)].

Authors:  C Glanzmann; W Horst
Journal:  Strahlentherapie       Date:  1979-04

5.  Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.

Authors:  C C Kuni; W C Klingensmith
Journal:  Radiology       Date:  1980-12       Impact factor: 11.105

Review 6.  The treatment of thyroid carcinoma with radioactive iodine.

Authors:  W H Beierwaltes
Journal:  Semin Nucl Med       Date:  1978-01       Impact factor: 4.446

7.  Carcinoma of the thyroid gland.

Authors:  K Shimaoka; K Sako; M Friedman; S Bakshi; U Rao
Journal:  Int Adv Surg Oncol       Date:  1980

8.  The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication.

Authors:  A Waxman; L Ramanna; N Chapman; D Chapman; M Brachman; D Tanasescu; D Berman; B Catz; G Braunstein
Journal:  J Nucl Med       Date:  1981-10       Impact factor: 10.057

9.  Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.

Authors:  A R Siddiqui; J Edmondson; H N Wellman; R C Hamaker; R E Lingeman; H M Park; C C Johnston
Journal:  Clin Nucl Med       Date:  1981-04       Impact factor: 7.794

10.  Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer.

Authors:  S R Thomas; H R Maxon; J G Kereiakes; E L Saenger
Journal:  Radiology       Date:  1977-03       Impact factor: 11.105

View more
  2 in total

1.  High or low dose radioiodine ablation of thyroid remnants?

Authors:  H Creutzig
Journal:  Eur J Nucl Med       Date:  1987

Review 2.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.